| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 05/24/2001 | US20010001709 Methods for enhancing the production of viral vaccines in cell culture |
| 05/24/2001 | US20010001673 Process for the preparation of malted cereals |
| 05/24/2001 | US20010001662 To treat a behavioral or psychological deficit such as caused by ischema in an animal; intracerebral transplantation; obtaining said cells from human fetus, immortalization of cells |
| 05/23/2001 | EP1101412A2 Use of a high-ester pectin in acidic, protein-containing foodstuffs |
| 05/23/2001 | EP1101112A2 Leptin-mediated gene-induction |
| 05/23/2001 | EP1100950A1 Gastrointestinal bacterial antibody factories |
| 05/23/2001 | EP1100947A1 Method for the production of an antibiotic agent |
| 05/23/2001 | EP1100945A2 Latency-active regulatory sequences of herpesviruses and lantency-inactive herpesviruses for gene transfer |
| 05/23/2001 | EP1100944A1 Targeted alphavirus and alphaviral vectors |
| 05/23/2001 | EP1100942A2 Herpes virus vectors for dendritic cells |
| 05/23/2001 | EP1100934A1 Herpesvirus preparations and their uses |
| 05/23/2001 | EP1100932A2 Method for autoactivation of procaspase 8 |
| 05/23/2001 | EP1100928A2 Enzymes for biopolymer production |
| 05/23/2001 | EP1100921A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/23/2001 | EP1100920A2 Nucleic acids and proteins from group b streptococcus |
| 05/23/2001 | EP1100915A2 Fibrous proteins and the production thereof |
| 05/23/2001 | EP1100911A1 Eukaryotic cell-based gene interaction cloning |
| 05/23/2001 | EP1100909A2 Dna replication- and repair-associated proteins |
| 05/23/2001 | EP1100908A2 Human receptor-associated proteins |
| 05/23/2001 | EP1100899A2 Delta-related polypeptides |
| 05/23/2001 | EP1100898A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/23/2001 | EP1100893A1 Nucleic acids encoding proteins involved in sensory transduction |
| 05/23/2001 | EP1100891A2 Expression of functional eukaryotic proteins |
| 05/23/2001 | EP1100890A2 Improved transformation efficiency in phage display through modification of a coat protein |
| 05/23/2001 | EP1100871A2 Method for preparing a cartilage cell suspension |
| 05/23/2001 | EP1100868A1 Process for preparing starter cultures of lactic acid bacteria |
| 05/23/2001 | EP1100830A2 Heterominibodies |
| 05/23/2001 | EP1100828A1 Antibodies against beer spoilage lactic acid bacteria and their diagnostic use |
| 05/23/2001 | EP1100826A1 Isoforms of human calcium sensing receptor |
| 05/23/2001 | EP1100810A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 05/23/2001 | EP1100542A2 Peg-urate oxidase conjugates and use thereof |
| 05/23/2001 | EP0683784B1 7,42-bis (o-demethyl) rapamycin |
| 05/23/2001 | EP0623170B1 Vaccines based on streptokinase |
| 05/23/2001 | EP0572433B1 Antigen-presenting capsid with fusion ms2-coat protein |
| 05/23/2001 | DE19955408A1 New invertebrate gamma-aminobutyric acid receptor proteins, useful in screening for potential insecticides, for plant protection or medicine, also related nucleic acid |
| 05/23/2001 | CN1296527A Mortierella |
| 05/23/2001 | CN1296172A Mannose quantitatively determining method and reagent thereof |
| 05/23/2001 | CN1066198C Method for controlling plant pathogens |
| 05/23/2001 | CA2324485A1 Novel nucleotide sequences coding for the pfka gene |
| 05/23/2001 | CA2323750A1 New nucleotide sequences which code for the pfk gene |
| 05/22/2001 | US6235974 Administering polypeptide |
| 05/22/2001 | US6235525 Nucleotide sequence; diagnosis; vaccines; transfected cell line |
| 05/22/2001 | US6235522 Lentiviral vectors |
| 05/22/2001 | US6235516 From rhodococcus globerulus, rhodococcus equi or arthrobacter aurescens |
| 05/22/2001 | US6235515 Malathion carboxylesterase |
| 05/22/2001 | US6235511 Compositions prepared to contain active dextran sucrase produced by Leuconostoc mesenteroides ssp. cremoris |
| 05/22/2001 | US6235507 High-yield process by cultiviating streptomyces setonii in nutrient broth for 5 hours, adding ferulic acid to concentration of 5 to 40 grams per liter, incubating broth for 5 to 50 hours, and recovering produced vanillin |
| 05/22/2001 | US6235506 Process for the fermentative preparation of clavam derivatives whereby the levels of ammonia and urea in the fermentation medium are kept low |
| 05/22/2001 | US6235499 Genetic engineering |
| 05/22/2001 | US6235498 Propagating mammalian aggregations; transform aggregates with nucleotide sequences which express insulin and heterologous polypeptide, propagate aggregates |
| 05/22/2001 | US6235497 Viral vector coding rodent transport protein; for treatment of nervous system disorders |
| 05/22/2001 | US6235496 Nucleic acid encoding mammalian mu opioid receptor |
| 05/22/2001 | US6235480 Screening for the presence of target nucleotide sequences; incubate preferential nucleotide sequences with enzymes and screen for preferentially released nucleotides |
| 05/22/2001 | US6235465 HTLV-1 probes for use in solution phase sandwich hybridization assays |
| 05/22/2001 | US6235285 An isolated polypeptide comprising a heterologous amino acid sequence fused to specific polynucleotide sequence |
| 05/22/2001 | CA1341235C Modular assembly of antibody genes, antibodies prepared thereby and use |
| 05/17/2001 | WO2001034830A2 Assay of micro-organisms in cell cultures |
| 05/17/2001 | WO2001034784A1 Fungamyl-like alpha-amylase variants |
| 05/17/2001 | WO2001034780A2 Cytochrome p450 oxygenases and their uses |
| 05/17/2001 | WO2001034777A1 Symbiotic bacteria and their uses |
| 05/17/2001 | WO2001034206A2 Nucleic acid-containing complex |
| 05/17/2001 | WO2001034168A1 Inhibition of pathogens by bacillus coagulans strains |
| 05/17/2001 | WO2001034092A2 A novel medium for the production of betacarotene and other carotenoids from dunaliella salina (arl 5) and a strain of dunaliella salina for production of carotenes using the novel media |
| 05/17/2001 | WO2001012598A9 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 05/17/2001 | WO2000049137B1 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
| 05/17/2001 | WO1995002040A3 New stromal cell lines from human bone marrow and their use |
| 05/17/2001 | US20010001310 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes |
| 05/17/2001 | US20010001290 Methods for enhancing the production of viral vaccines in cell culture |
| 05/17/2001 | CA2416827A1 A novel medium for the production of betacarotene and other carotenoids from dunaliella salina (arl 5) and a strain of dunaliella salina for production of carotenes using the novel media |
| 05/17/2001 | CA2390504A1 Cytochrome p450 oxygenases and their uses |
| 05/17/2001 | CA2390144A1 Assay of micro-organisms in cell cultures |
| 05/17/2001 | CA2389982A1 Inhibition of pathogens by bacillus coagulans strains |
| 05/17/2001 | CA2389506A1 Nucleic acid-containing complex |
| 05/17/2001 | CA2325226A1 Use of polypeptides or nucleic acids encoding these for the diagnosis or treatment of skin disorders, and their use for the identification of pharmacologically active substances |
| 05/17/2001 | CA2324414A1 Cytochrome c oxidase enzyme complex |
| 05/16/2001 | EP1099765A1 Quantitative determination method of mannose and reagent therefor |
| 05/16/2001 | EP1099759A2 Vibrio cholerae vaccine candidates and methods of their constructing |
| 05/16/2001 | EP1099758A2 Method and host cells for producing two-chain relaxin polypeptide |
| 05/16/2001 | EP1099755A1 Novel gene and transformant carrying the same |
| 05/16/2001 | EP1099753A1 Method for growing Burkholderia cepacia in a cobalt-containing medium and use thereof for degradating TBA or TAA |
| 05/16/2001 | EP1098980A2 $i(STREPTOCOCCUS SUIS) VACCINES AND DIAGNOSTIC TESTS |
| 05/16/2001 | EP1098974A2 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 05/16/2001 | EP1098962A2 Diacylglycerol acyl transferase proteins |
| 05/16/2001 | EP1098958A1 Method for providing a substrate structure for oriented neurite outgrowth, substrate structure, and device for monitoring neurons |
| 05/16/2001 | EP1098908A2 Anti-ccr2 antibodies and methods of use therefor |
| 05/16/2001 | EP1084709A9 Oral recombinant lactobacilli vaccines |
| 05/16/2001 | EP0728211B1 Process of producing highly transformable bacterial cells and cells produced thereby |
| 05/16/2001 | CN1295610A Acidic cleaning composition comprising acidic protease |
| 05/16/2001 | CN1295131A Method for production of L-lysine using coryneform bacterial fermentation |
| 05/16/2001 | CN1295127A Plasmid from glutamic acid coryneform and its use |
| 05/16/2001 | CN1065916C Polypeptides relating biology synthetic cobalamins and/or cobamides, coding DNA sequence of polypeptides, process for preparing them and use |
| 05/16/2001 | CN1065914C Biosynthesized serine and its related product and process |
| 05/16/2001 | CN1065909C Microorganisms for production of tryptophan and process for preparation thereof |
| 05/16/2001 | CN1065768C Methods of treatment of motor neuron cliseases using members of BDNF/NT-3/NGF family of molecule |
| 05/15/2001 | US6232458 Proteins used in pharmaceutical human and veterinary applications; adapted to provide enhanced expression |
| 05/15/2001 | US6232452 Autosomal dominant disorder of growths in many tissues and organs identified on chromosome 16 deletion mutations; use in disease diagnosis and screening; the gene may behave as a tumor suppressor |
| 05/15/2001 | US6232448 Immunological materials and methods for detecting dihydropyrimidine dehydrogenase |
| 05/15/2001 | US6232441 PIGR-1, a member of immunoglobulin gene superfamily |
| 05/15/2001 | US6232292 3-dehydroquinate synthase |
| 05/15/2001 | US6232286 Methods of stimulating mitogenesis in glial cells using glial mitogenic factors |